Methylphenidate and suicidal ideation: Report of two cases
Authors:
Open Access
- 1 January 2014
- journal article
- case report
- Published by Medknow in Indian Journal of Psychiatry
- Vol. 56 (1) , 79-81
Abstract
Stimulant prescriptions are routinely used to treat Attention Deficit Hyperactivity Disorder. Reports of psychiatric symptoms that have occurred include euphoria, delirium, confusion, toxic psychosis, and hallucinations. Here, authors report two cases of Attention Deficit Hyperactivity Disorder who were prescribed methylphenidate. Both children developed suicidal ideation that abated after discontinuing the drug. There were no depressive symptoms reported along with it, and the ideation could not be explained on the basis of impulsivity either.Keywords
This publication has 7 references indexed in Scilit:
- Safety of Attention-Deficit/Hyperactivity Disorder Medications in Children: An Intensive Pharmacosurveillance Monitoring StudyJournal of Child and Adolescent Psychopharmacology, 2012
- Parental Reporting of Adverse Drug Reactions Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Medications in Children Attending Specialist Paediatric Clinics in the UKDrug Safety, 2011
- Oral megadose methylphenidate ingestion for suicide attemptPediatrics International, 2009
- Methylphenidate: Its Pharmacology and UsesMayo Clinic Proceedings, 2000
- Methylphenidate: Its Pharmacology and UsesMayo Clinic Proceedings, 2000
- Safety Issues in the Use of Methylphenidate An American PerspectiveDrug Safety, 1997
- Effects of Methylphenidate on Extracellular Dopamine, Serotonin, and Norepinephrine: Comparison with AmphetamineJournal of Neurochemistry, 1997